Max Healthcare Institute Past Earnings Performance
Past criteria checks 2/6
Max Healthcare Institute has been growing earnings at an average annual rate of 49.2%, while the Healthcare industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 26.1% per year. Max Healthcare Institute's return on equity is 12%, and it has net margins of 17.6%.
Key information
49.2%
Earnings growth rate
46.0%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 26.1% |
| Return on equity | 12.0% |
| Net Margin | 17.6% |
| Next Earnings Update | 30 Jan 2025 |
Recent past performance updates
Recent updates
We Think Max Healthcare Institute (NSE:MAXHEALTH) Can Stay On Top Of Its Debt
Nov 30
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Nov 09Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now
Sep 14Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?
Jul 18Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark
Jun 21Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know
May 25Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today
Apr 14Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors
Mar 18Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 03Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly
Jan 08Revenue & Expenses Breakdown
How Max Healthcare Institute makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 60,083 | 10,590 | 12,508 | 0 |
| 30 Jun 24 | 56,640 | 10,538 | 11,734 | 0 |
| 31 Mar 24 | 54,060 | 10,576 | 11,169 | 0 |
| 31 Dec 23 | 51,976 | 10,570 | 11,689 | 0 |
| 30 Sep 23 | 50,044 | 9,901 | 11,354 | 0 |
| 30 Jun 23 | 47,807 | 11,708 | 10,201 | 0 |
| 31 Mar 23 | 45,626 | 11,035 | 9,863 | 0 |
| 31 Dec 22 | 42,799 | 9,763 | 10,066 | 0 |
| 30 Sep 22 | 41,143 | 9,437 | 9,753 | 0 |
| 30 Jun 22 | 39,976 | 6,310 | 8,699 | 0 |
| 31 Mar 22 | 39,366 | 6,051 | 8,729 | 0 |
| 31 Dec 21 | 37,978 | 5,510 | 8,230 | 0 |
| 30 Sep 21 | 36,193 | 4,516 | 7,797 | 0 |
| 30 Jun 21 | 32,486 | 3,236 | 6,514 | 0 |
| 31 Mar 21 | 25,080 | -1,375 | 5,657 | 0 |
| 31 Dec 20 | 27,772 | -1,177 | 2,199 | 0 |
| 30 Sep 20 | 22,487 | -2,134 | 1,121 | 0 |
| 30 Jun 20 | 14,849 | -2,681 | -613 | 0 |
| 31 Mar 20 | 10,590 | 590 | 3,049 | 0 |
| 31 Dec 19 | 10,081 | 268 | 761 | 0 |
| 30 Sep 19 | 18,609 | 720 | 549 | 0 |
| 30 Jun 19 | 17,719 | 360 | 709 | 0 |
| 31 Mar 19 | 16,939 | -30 | 759 | 0 |
| 30 Jun 18 | 17,053 | -704 | 765 | 0 |
| 31 Mar 18 | 17,303 | -302 | 838 | 0 |
| 31 Mar 17 | 16,085 | -14 | 721 | 0 |
| 31 Mar 16 | 14,343 | -180 | 698 | 0 |
| 31 Mar 15 | 7,896 | -381 | 409 | 0 |
| 31 Mar 14 | 9,445 | -646 | 132 | 0 |
Quality Earnings: MAXHEALTH has high quality earnings.
Growing Profit Margin: MAXHEALTH's current net profit margins (17.6%) are lower than last year (19.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MAXHEALTH's earnings have grown significantly by 49.2% per year over the past 5 years.
Accelerating Growth: MAXHEALTH's earnings growth over the past year (7%) is below its 5-year average (49.2% per year).
Earnings vs Industry: MAXHEALTH earnings growth over the past year (7%) did not outperform the Healthcare industry 31.4%.
Return on Equity
High ROE: MAXHEALTH's Return on Equity (12%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 03:38 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Max Healthcare Institute Limited is covered by 30 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Prashant Nair | Ambit Capital |
| null null | Anand Rathi Shares and Stock Brokers Limited |